Online research company Reportlinker has released a report by the title of “Nanobiotechnology: Applications and Global Markets”. For the purpose of the study BCC, which has so far analysed around 115 nanobiotechnology companies was chosen and the study was headed by John Bergin.
The report has analysed the global nanobiotechnology market in terms of current and future market segments, market status and technology. It has also studied the factors that drive or hinder the growth of the market such as trends of patents, biological imaging, structure of the industry and the requirement for drug delivery. Taking these factors into consideration, the report has given a five year forecast of the market’s growth with specific focus on medical applications market and R&D tools market.
According to the report the global nanobiotechnology market stood at $19.3 billion in 2010 and is expected to reach $29.7 billion through a compounded annual growth rate (CAGR) of 9%. While the market for medical applications such as microbicides and drug delivery is likely to achieve a CAGR of 8.7% to reach $29 billion in 2015 from $19.1 billion in 2010, the R&D tools market is expected to reach $305 million in 2015 from $63 million in 2010 through a CAGR of 37%. Companies from specific nanobiotechnology industries that include medical devices, biotechnology, polymers, biologic imaging materials, nanomaterials, diagnostics, life science tools and pharmaceuticals , DNA sequencing , and manufacturers of quantum dots, nanopores, nanocrystals, dendrimers, polymer nanoparticles and biochips will benefit from the findings of the report. Several breakthrough researches in the field of nanobiotechnology have been emerging thus creating a need to identify major trends in the industry so that businesses can take informed decisions.
Source: http://www.reportlinker.com